Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-04

FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for Desipramine hydrochloride by Amneal Pharmaceuticals NY LLC, authorizing the generic product (ANDA 208105).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESIPRAMINE HYDROCHLORIDE (Desipramine hydrochloride)

Snippet

SUPPL AP for DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE)